Cortagen: Neuronal Research in Cellular Aging and Stress Models

Cortagen is a synthetic tetrapeptide (Ala-Glu-Asp-Pro) developed by the Saint Petersburg Institute of Bioregulation and Gerontology as part of Vladimir Khavinson's tissue-specific peptide bioregulator research programme. It is classified as a neurotrophin-like peptide bioregulator targeting cortical neuron function in aging.

The Bioregulator Peptide Framework

The theoretical framework for Cortagen and related bioregulators posits that short oligopeptides derived from specific organ tissues act as regulatory signals — activating gene expression patterns characteristic of younger, more functional cells. Khavinson published a comprehensive review in *Bulletin of Experimental Biology and Medicine* (2010) proposing that short tissue-derived peptides bind to chromatin and DNA-regulatory proteins, reactivating youthful gene expression patterns.

For nervous tissue-targeted bioregulators like Cortagen, the proposed target genes include neurotrophin genes (BDNF, NGF, NT-3), synaptic plasticity genes, and neuroprotective enzymes — similar in intended target to Semax, which upregulates BDNF through a better-characterised melanocortin receptor mechanism.

Mechanism: Chromatin Binding and Gene Activation

In nuclear extracts from rat cerebrocortical neurons, Cortagen (Ala-Glu-Asp-Pro) preferentially binds AT-rich promoter sequences in histone protein complexes. In isolated cerebrocortical neuron cultures:

• BDNF mRNA: increased approximately 40% vs untreated cultures at 48h (Khavinson VK et al., *Bulletin of Experimental Biology and Medicine*, 2008)
• MAP2 expression (dendritic branching marker): increased
• Apoptosis in H2O2-stressed neurons: reduced approximately 25%

Stress Resilience Models

In oxidative stress (H2O2 model) and excitotoxic stress (glutamate model) of cortical neurons:

• H2O2 model: Cortagen pre-treatment reduced neuronal death by 20-30%
• Glutamate model: Cortagen reduced caspase-3 activation by approximately 30%

In aged rats (24-month-old Wistar), subcutaneous Cortagen at 10 mcg/kg for 10 days improved Morris Water Maze performance compared to vehicle controls — with performance approaching that of 6-month-old young adults.

Evidence Quality Assessment

Research on Cortagen has been conducted almost exclusively within Khavinson's group. Western independent replication and peer-reviewed clinical data are absent. The mechanistic hypothesis (DNA-binding peptides modulating gene expression) has precedent in broader chromatin-regulatory peptide literature, but evidence quality and volume is far lower than for established neuropeptides like Semax (Russia regulatory approval, multiple published RCTs) or Epithalon (extensive preclinical evidence from the same group).

Cortagen is a research compound not available as a pharmaceutical in most Western jurisdictions.

<!-- deep-links-v1 -->

Related Bioregulator Peptides in Aging Research

Cortagen belongs to the Khavinson peptide bioregulator family, alongside a wide range of tissue-specific compounds. Cartalax (Ala-Glu-Asp-Gly) is the cartilage and joint bioregulator studied for chondrocyte activity restoration in aged models. Vesugen, the vascular bioregulator, targets endothelial cell gene expression to counter age-related vascular stiffening. Sigumir addresses cartilage matrix preservation, relevant in age-related osteoarthritis models. Pielotax is the renal bioregulator studied for tubular cell protection in aging kidney models. PTD-DBM, a cell-penetrating peptide that activates Wnt signaling, promotes tissue progenitor cell differentiation in regenerative contexts. Livagen, a hepatic and immune bioregulator, restores chromatin decondensation in aged lymphocytes, making it a key reference in DNA-accessibility aging research.

Neuroprotective and Pineal Bioregulators

Pinealon, the tripeptide EDR, is studied for neuroprotective gene expression modulation in brain aging models alongside cortagen's cardiovascular targets. Crystagen, a crystallin lens bioregulator, addresses the visual system dimension of aging. Cerluten, a cerebral cortex bioregulator, is studied for age-related cognitive function support. Endoluten, the pineal bioregulator, complements cortagen's cardiovascular work with circadian and hormonal aging regulation.